Enhancement of Intravenous Thrombolysis by Nationwide Telestroke Care in Slovenia: A Model of Care for Middle-Income Countries

Telemed J E Health. 2020 Apr;26(4):462-467. doi: 10.1089/tmj.2019.0046. Epub 2019 May 29.

Abstract

Background:Stroke expertise is critical for timely and appropriate intravenous thrombolysis (IVT) and affects IVT use.Introduction:In Slovenia, IVT is administered in general hospitals, which often lack on-site neurologic expertise. To overcome this obstacle, a national telestroke network, TeleKap, has been implemented. The aim of the study was to determine whether TeleKap is associated with enhanced IVT use.Materials and Methods:This investigation was a retrospective observational study comparing the number of acute ischemic stroke (AIS) patients and the use of IVT during the first 3 consecutive years. TeleKap, a decentralized hub-and-spoke telestroke model covering the entire nation, consists of one comprehensive stroke center and 12 spokes classified according to the availability of on-site neurologic expertise.Results:During the observation period, we treated a total of 1,316 patients with AIS, of which 508 (38.6%) received IVT. We found statistically significant positive trends in the number of IVT patients (142 in 2015, 158 in 2016, and 208 in 2017; B = 4.39, standard error (SE) = 1.59, p = 0.01) and the number of AIS patients (326 in 2015, 424 in 2016, and 566 in 2017; B = 14.42, SE = 5.19, p = 0.01) for all spokes. The trend in the IVT rate was numerically negative but did not reach statistical significance (43.5% in 2015, 37.3% in 2016, and 36.7% in 2017; p = 0.30).Discussion:TeleKap enhanced IVT use regardless of on-site neurologic expertise.Conclusions:TeleKap proved to be efficient. It could serve as a model of telestroke care for other similar countries.

Keywords: intravenous thrombolysis; ischemic stroke; middle-income country; model-of-care; telemedicine; telestroke.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain Ischemia* / drug therapy
  • Developing Countries
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Slovenia
  • Stroke* / drug therapy
  • Telemedicine*
  • Thrombolytic Therapy
  • Tissue Plasminogen Activator / therapeutic use
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator